Le Lézard
Classified in: Health, Business

University House Issaquah Named to Caring Stars 2019 List


ISSAQUAH, Wash., Dec. 16, 2018 /PRNewswire-PRWeb/ -- University House Issaquah is one of only two retirement communities in King County, Washington on the Caring.com Caring Stars 2019 List. To earn the designation Caring.com considers consumer ratings and reviews from family caregivers and residents of senior living communities. In all, 128 retirement communities in 33 states made the list, representing just 0.5 percent of senior housing communities nationwide.

Those who reviewed University House Issaquah consistently remarked about five important lifestyle factors including:

"We are delighted to be recognized by Caring.com as a top retirement community," said University House Issaquah Executive Director Esther Friend.

University House Issaquah is located at 22975 SE Black Nugget Road in Issaquah, Washington. The community is in a neighborhood setting, and close to a retail center and several healthcare clinics.

University House Issaquah is part of Era Living, a private, Seattle-based company of eight premier retirement communities. University House Issaquah offers a vibrant lifestyle with ongoing learning programs for residents, beautiful Cascade vistas, compassionate Independent Living and Assisted Living services, and Memory Support care.

 

SOURCE University House Issaquah


These press releases may also interest you

at 10:31
GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint
Recently, GenScript Biotech Corporation (HK.1548), a world leader in technologies and services for life science R&D and manufacture, released its 2023 Environmental, Social, and Governance (ESG) report. This report showcases the company's dedicated...

at 10:30
Vaccines Market Worth $94.9 billion | MarketsandMarketstm
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of 4.0% from 2024 to 2029 according to a new report by MarketsandMarketstm. Similarly, the vaccines...

at 10:25
Aulos Bioscience to Present Updated Phase 1/2 Clinical Trial Results for Novel IL-2 Therapeutic AU-007 in Advanced Solid Tumor Cancers at 2024 ASCO Annual Meeting
Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that updated Phase 1/2 data for AU-007 will be presented at the American Society...

at 10:20
Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers
A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in Chicago, Illinois. The COVID-19 Monument of Honor, Remembrance, and Resilience...

at 10:20
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting
Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced clinical data from the pivotal Phase 2 study of PRGN-2012 AdenoVerse immunotherapy...

at 10:20
BioInvent to Present Clinical Data from its Two Leading Assets at ASCO 2024
The two poster presentations will report -first combination data from the Phase 1/2a study with BI-1808 in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), as well as an update on monotherapy armcombination data from the...

More news about Health...


News published on and distributed by: